摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-methoxyphenyl)benzimidoyl chloride | 59386-96-8

中文名称
——
中文别名
——
英文名称
N-(2-methoxyphenyl)benzimidoyl chloride
英文别名
Benzoesaeure-<2-methoxy-phenylimid>-chlorid;N-(2-methoxyphenyl)benzenecarboximidoyl chloride
N-(2-methoxyphenyl)benzimidoyl chloride化学式
CAS
59386-96-8
化学式
C14H12ClNO
mdl
——
分子量
245.708
InChiKey
KLYMEZRMPXETGC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    21.6
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    N-(2-methoxyphenyl)benzimidoyl chloridesodium ethanolate 作用下, 以 乙醚乙醇 为溶剂, 生成 N-<2-Methoxy-phenyl>-N-<3-methoxycarbonyl-phenyl>-benzamid
    参考文献:
    名称:
    Messer,M.; Farge,D., Bulletin de la Societe Chimique de France, 1968, p. 2832 - 2842
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    氧化银(II)介导的2,4-二芳基喹唑啉的合成
    摘要:
    描述了合成2,4-二芳基喹唑啉的单釜法,该法涉及氧化银介导的C H活化/ C N键形成过程。提出了有关取代基效应的通用方法以及导致工艺优化的研究。机理研究为自由基中间体参与反应过程提供了支持。
    DOI:
    10.1016/j.tetlet.2018.05.019
点击查看最新优质反应信息

文献信息

  • Silver(II) oxide-mediated synthesis of 2,4-diarylquinazolines
    作者:Wing Cheung、Raymond J. Patch、Mark R. Player
    DOI:10.1016/j.tetlet.2018.05.019
    日期:2018.6
    4-diarylquinazolines is described which involves a silver oxide-mediated CH activation/CN bond formation process. The generality of this method with respect to substituent effects is presented along with studies leading to process optimization. Mechanistic investigations provide support for the involvement of radical intermediates in the reaction process.
    描述了合成2,4-二芳基喹唑啉的单釜法,该法涉及氧化银介导的C H活化/ C N键形成过程。提出了有关取代基效应的通用方法以及导致工艺优化的研究。机理研究为自由基中间体参与反应过程提供了支持。
  • Potential antitumor agents. 40. Orally active 4,5-disubstituted derivatives of amsacrine
    作者:William A. Denny、Graham J. Atwell、Bruce C. Baguley
    DOI:10.1021/jm00369a021
    日期:1984.3
    5-disubstituted derivatives all showed high activity when administered ip against ip-implanted P-388, but activity varied widely when the compounds were given orally. 4-Methoxy and 4-carbamoyl derivatives proved essentially inactive, whereas 4-methyl and 4-methylcarbamoyl derivatives retained activity. Exceptional oral activity was shown by the 4-methyl-5-methylcarbamoyl derivative, making this amsacrine
    DNA嵌入剂amsacrine是治疗人类白血病和淋巴瘤的有效药物,但实体瘤活性极低。作为鉴定具有更广谱活性的类似物的第一步,对通过口服(po)和腹膜内(ip)途径给予的Amsacrine类似物的体内抗白血病(P-388)活性进行了比较。一系列的4-取代和4,5-二取代的衍生物在ip注射时对ip植入的P-388均显示出高活性,但是当口服给予化合物时,活性变化很大。事实证明4-甲氧基和4-氨基甲酰基衍生物基本上没有活性,而4-甲基和4-甲基氨基甲酰基衍生物保持活性。4-甲基-5-甲基氨基甲酰基衍生物显示出非凡的口服活性,使该氨溴萘衍生物值得进一步测试。
  • Chemistry and hypoglycemic activity of benzimidoylpyrazoles
    作者:James R. Shroff、Victor Bandurco、Rohit Desai、Sidney Kobrin、Peter Cervoni
    DOI:10.1021/jm00144a031
    日期:1981.12
    (tolazamide, phenformin, and buformin) in several experimental models show that these compounds seem to combine in one molecule some of the biological activities of the beta-cytotrophic sulfonylureas and some of the activities of the biguanides. A synthetic scheme for the preparation of the benzimidolypyrazoles and a preliminary structure-activity relationship are presented.
    合成了一系列苯并亚氨基酰基吡唑类,并作为降血糖药进行了评估。1-(N-环己基苯并亚甲基)-5-甲基-3-吡唑甲酸甲酯(13)和1- [N-(4-甲氧基苯基)苯并亚甲基] -5-甲基-3-吡唑甲酸甲酯(33)是其中两个更有趣的化合物。在几个实验模型中将这些苯甲亚氨基酰基吡唑类与经典标准品(甲苯磺酰胺,苯乙双胍和丁二甲酰胺)进行比较,结果表明,这些化合物似乎在一个分子中结合了β-细胞营养性磺酰脲类的某些生物活性和双胍类的某些活性。提出了合成苯甲酰亚胺基吡唑的合成方案,并初步建立了结构-活性关系。
  • Familial Aggregation of 7-Year Changes in Musculoskeletal Fitness
    作者:P. T. Katzmarzyk、N. Gledhill、L. Perusse、C. Bouchard
    DOI:10.1093/gerona/56.12.b497
    日期:2001.12.1
    The purpose of this study was to determine the degree of familial resemblance in baseline and 7-year changes in musculoskeletal fitness. Data front the 1981 Canada Fitness Survey and the Campbell's Survey 7-year follow-up were used. The sample consisted of 1264 people (635 males and 629 females) between the ages of 7 and 69 years for whom measurements of musculoskeletal fitness were available at baseline. A subsample of 834 people had measurements at both baseline and 7-year follow-up. Sit-and-reach trunk flexibility, number of push-ups without time limit, number of sit-ups in 60 seconds, and hand-grip strength were used as indicators of musculoskeletal fitness. The data were adjusted for the effects of age and body mass index (and baseline level of the variable for changes) by using regression procedures, and they were standardized to zero mean and unit variance within each of the four sex-by-generation groups (fathers, mothers, sons, and daughters), Familial correlation models were fitted to the data by using the computer software SEGPATH. The results indicate significant familial resemblance for all indicators of musculoskeletal fitness for baseline measures and 7-year changes. The heritabilities, or the percentages of the total variance attributable to heredity, were 64% for trunk flexibility, 37% for push-ups, 59% for sit-ups, and 48% for grip strength. Similarly, heritabilities for the change scores were 48% for trunk flexibility, 52% for push-ups, 41% for sit-ups, and 32% for grip strength. The results suggest that familial, and perhaps genetic, factors are important in explaining the variance in musculoskeletal fitness not only cross-sectionally but also for changes over time.
  • Fabian et al., Bulletin de la Societe Chimique de France, 1956, p. 287,291
    作者:Fabian et al.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐